Controlled attenuation parameter for non‐invasive assessment of hepatic steatosis: Does etiology affect performance?

Abstract

CAP is a novel, non-invasive tool that can detect and quantify steatosis accurately among CHBV, CHCV, and NAFLD patients, the accuracy being similar for all the three groups of patients.